Évènement

Key advances on immunotherapy and cellular therapy against cancer and inflammatory diseases




EUROBIOMED presents: key advances and future promises in immunotherapy antibodies and cellular therapies for the treatment of cancers and inflammatory diseases.

Over the last years, immunotherapies have shown very good results notably with the last generation of treatments combining different approaches for the treatment of melanoma and NSCLC. But despite the success and hope, these treatments generate severe adverse reactions, a high proportion of people still do not respond to immunotherapy, and their use in some pathologies are still in the preclinical phase. Lots of efforts are made in order to increase efficacy with new targets, new formats, combination of treatments and with the development of cellular therapies targeting the immune system. All these aspects will be addressed during this one day symposium and we will benefit from the point of view of the French pharmaceutical industry.

Program

8h30

Registration and Coffee

9h00

Welcome words and Eurobiomed presentation

- Emilie Royere, Directrice Générale du Pôle Eurobiomed

9h20

Opening Lecture

- Name to be confirmed

10h00

The next generation of immunotherapy to increase efficacy (Part I)

- Dr. Jean-Jacques Fournié (CRCT - Toulouse)

- M. René Hoet (Imcheck Therapeutics - Marseille)

10h40

Coffee Break

11h00

The next generation of immunotherapy to increase efficacy (Part II)

- Dr. Julien Faget (IRCM - MabImprove - Montpellier)

- M. Nicolas Poirier (Ose Immunotherapeutics - Nantes)

- Dr. Bruno Ségui (CRCT - Toulouse)

- M. Hatem Azim (Innate Pharma - Marseille)

12h20Lunch and networking
13h40

Afternoon Lecture

- Prof. Christian Chabannon (CTCG, IPC - AP-HM - Marseille)
14h20

New cellular and genetic approaches to treat diseases

- Dr. Martin Villalba (IRMB - Montpellier)

- Mrs. Pascale Bouillé (Flash Therapeutics - Toulouse)

- Dr. Julio Delgado (Hospital Clinic Barcelona)

- Mrs. Caroline Courme (Sangamo - Nice)

15h40Coffee Break
16h00The pharmaceutical industry's point of view

Sanofi - Servier - Pierre Fabre

17h00Conference closing

Chairmen : Prof. John De Vos (IRMB - Montpellier) and Prof. Pierre Martineau (IRCM - Montpellier)

Register Here

Register before the 20th of March 2019.

 

Information : Nicolas REYMOND : nicolas.reymond(at)eurobiomed(dot)org

 

With the support of


              

 

In partnership with